RO_GreenJournal Profile Banner
Radiotherapy & Oncology Profile
Radiotherapy & Oncology

@RO_GreenJournal

Followers
4K
Following
32
Media
28
Statuses
915

As the flagship journal of ESTRO we aim to publish the best science in the field of radiation oncology serving a multi-professional cancer community.

Joined June 2020
Don't wanna be here? Send us removal request.
@RO_GreenJournal
Radiotherapy & Oncology
2 months
RT @TipsroTweets: We’re moving our updates and conversations from Twitter X to LinkedIn! 🚀Follow us at TipsRO LinkedIn page .
0
3
0
@RO_GreenJournal
Radiotherapy & Oncology
2 months
🚀 Thrilled to announce 3 new clinical trials in Radiotherapy & Oncology in partnership with @TheLancetOncol Lancet Oncology):. ✨ ESO-SPARE.🔍 DBCG IMN2 post-hoc.📊 FAST-Forward nodal sub-study.More details coming soon! 👀 #ESTRO2025 #GreenJournal.
1
12
39
@RO_GreenJournal
Radiotherapy & Oncology
2 months
We’re no longer posting here. Join us on LinkedIn for the latest updates! 📢.Catch our Editor-in-Chief Pierre Blanchard in a new interview on:.✨ The evolving role of journals.🤝 Cross-journal collaboration.🌱 Tips for early-career researchers.🔗
1
2
12
@RO_GreenJournal
Radiotherapy & Oncology
3 months
We are really looking forward to this session! Can't wait to see you all there!.
@TheLancetOncol
The Lancet Oncology
3 months
A privilege to co-chair this @TheLancetOncol @RO_GreenJournal join session at #ESTRO2025 this weekend. See you there!.
0
0
5
@RO_GreenJournal
Radiotherapy & Oncology
3 months
📢 Don’t miss the Green Journal–Lancet Oncology joint plenary at #ESTRO2025!.🗓 Sun May 4 | ⏰ 11:40–12:45.📍 Plenary Hall.Top clinical trials in GI & SBRT from 🇬🇧 🇳🇱 🇨🇳 — including PLATO ACT 4, STAR-TREC, PRIME-RT & more. #Radiotherapy #Oncology #GreenJournal.
0
2
22
@RO_GreenJournal
Radiotherapy & Oncology
3 months
👏 A heartfelt thank you to our top reviewers over the past year at Radiotherapy & Oncology (The Green Journal)!.Your expertise, time, and dedication help uphold the highest standards in our field. We deeply appreciate your contributions. #PeerReview #GreenJournal
Tweet media one
1
2
21
@RO_GreenJournal
Radiotherapy & Oncology
3 months
🔬 New in The Green Journal: RTQA matters. This first meta-analysis links radiotherapy protocol deviations to worse survival in cancer trials. OS HR=1.65, PFS HR=1.79. Real-time QA could improve outcomes #RTQA #Oncology #RadOnc.
1
16
32
@RO_GreenJournal
Radiotherapy & Oncology
3 months
📢 Just 1 week to go until #ESTRO2025!.The abstract book is live — have you found yours?.👉 From AI to adaptive RT, this year’s programme is packed with innovation. What sessions are you most excited for?.#RadiationOncology #ESTROabstracts
Tweet media one
0
9
17
@RO_GreenJournal
Radiotherapy & Oncology
3 months
RT @oncodaily: Stereotactic reirradiation for in-field lung cancer recurrence after stereotactic ablative radiotherapy - Kevin Jang (@kevja….
0
1
0
@RO_GreenJournal
Radiotherapy & Oncology
3 months
🧠 New review sheds light on how to select and delineate post-op radiotherapy target volumes in oral cavity SCC. A must-read for H&N specialists.🔗#RadOnc #HeadandNeckCancer #OralCancer #Radiotherapy
Tweet media one
@DrMLChua
Melvin LK CHUA | FRCR, PhD, FASCO
3 months
1st part of #Radiotherapy Series that deep dives into #PORT for #Headneckcancer . Thanks to @ESTRO_RT and Team led by Profs_Mererid & Vincent with superb colleagues @sueyom @PierluigiBonomo . Part 2 on delineation otw! . Must read for residents! .
0
20
30
@RO_GreenJournal
Radiotherapy & Oncology
3 months
RT @kevjang_: Pleased to share our latest work in @RO_GreenJournal. In-field lung re-SABR achieves excellent outcomes with low toxicities.….
0
9
0
@RO_GreenJournal
Radiotherapy & Oncology
3 months
🔥 Can SABR work twice?.Meta-analysis shows in-field #SABR reirradiation offers 78% 1-year control with low toxicity—especially for small tumours, high BED (≥200 Gy), & long intervals. 💡 A safe, effective salvage option for recurrent #NSCLC. 📖 #radonc.
0
21
52
@RO_GreenJournal
Radiotherapy & Oncology
3 months
🤖 New in the Green Journal: Most radiation oncology patients support AI/ML in their care — but they want transparency, human connection, and equity. 📄 Read the study: #RadiationOncology #AIinHealthcare #GreenJournal #SocietyMatters #ESTRO.
1
7
12
@RO_GreenJournal
Radiotherapy & Oncology
3 months
🌍 Society Matters — a new section in the Green Journal!.Exploring how radiation oncology intersects with climate, equity, policy & more. 📖 Read the first editorial: 💬 What should we cover next? #RadiationOncology #SocietyMatters #ESTRO #Sustainability.
0
6
8
@RO_GreenJournal
Radiotherapy & Oncology
4 months
🚨 New study in The Green Journal: Salvage #radiotherapy with VMAT shows promising outcomes for recurrent #ProstateCancer after #HIFU. ✅ Low toxicity.✅ No recurrences during follow-up.✅ A potential standard of care?.#Oncology.
1
5
17
@RO_GreenJournal
Radiotherapy & Oncology
4 months
🚨 Call for Papers! The 4 ESTRO journals are uniting for a landmark issue on reirradiation—a cutting-edge approach offering new hope to patients with recurrent cancers. Submit your research & help shape the future of cancer care! 🔗 #Reirradiation #RadOnc
Tweet media one
0
8
23
@RO_GreenJournal
Radiotherapy & Oncology
4 months
📢 New ESTRO-EANO guideline in The Green Journal!.Recommendations for radiotherapy in IDH-mutant WHO grade 2 & 3 diffuse gliomas:.✅ Target volume delineation.✅ Imaging & planning techniques.✅ Dose & fractionation.A must-read for neuro-oncology teams!.
@valentinapinzi
valentinapinzi MD, PhD
4 months
Check out the latest recommendations for contouring low-grade gliomas – with practical insights on volumes, OARs, and imaging integration. A must-read for clinical practice and planning optimization. #RadOnc #NeuroOncology #Contouring #RTplanning. ⬇️⬇️⬇️.
0
27
47
@RO_GreenJournal
Radiotherapy & Oncology
4 months
RT @aftimosp: Investigator-initiated study sponsored by @JulesBordet and chaired by @AlexDeCaluwe and Laurence Buisseret. Primary endpoint….
0
3
0
@RO_GreenJournal
Radiotherapy & Oncology
4 months
PSMA PET after radiotherapy: Timing matters! ⏳ In 217 lesions, uptake declined over time, lowest at 9–12 months. Prostate lesions showed prolonged uptake vs. lymph nodes/bone. Beware of pseudo-progression on early scans! 📉 Full study:
@CalaisJeremie
Jeremie Calais
4 months
Kinetics of PSMA PET signal after radiotherapy in 217 prostate cancer lesions: It takes multiple months for the uptake to decrease (> 6 months). Beware of "pseudo-progression" on PSMA PET performed shortly after RT. @RO_GreenJournal @masatoshihotta @UCLA .
Tweet media one
0
25
53
@RO_GreenJournal
Radiotherapy & Oncology
4 months
🚀 New in Radiotherapy & Oncology: An adaptable cost-analysis framework for radiotherapy, applied to proton vs. photon therapy for lung cancer. Findings show protons remain costlier, but efficiency gains could reduce disparities📖 Read more: #PBT #photons.
0
0
2